Please login to the form below

Not currently logged in
Email:
Password:

Spravato

This page shows the latest Spravato news and features for those working in and with pharma, biotech and healthcare.

NICE knocks back J&J’s depression nasal spray Spravato

NICE knocks back J&J’s depression nasal spray Spravato

Cites clinical and pricing uncertainty as basis of rejection. Johnson &Johnson’s depression nasal spray Spravato has been hit with a rejection by the UK’s National Institute for Health and ... help more patients have a significant reduction in their

Latest news

More from news
Approximately 4 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
...
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics